Cancer Incidence and Mortality among Whites, New York City, 2015-2019

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 24025.4 452.4 449.8-455.0 11580.8 483.4 479.4-487.4 12444.6 437.9 434.4-441.5 7051.8 126.2 124.8-127.5 3460.2 146.5 144.3-148.7 3591.6 112.6 110.9-114.3
Oral cavity and pharynx 540.8 10.1 9.7-10.5 364.2 15.0 14.3-15.7 176.6 6.0 5.6-6.4 110.0 2.0 1.8-2.2 76.6 3.2 2.9-3.5 33.4 1.0 0.9-1.2
Esophagus 189.4 3.4 3.2-3.7 138.8 5.7 5.3-6.2 50.6 1.6 1.4-1.8 137.4 2.5 2.3-2.7 101.8 4.2 3.9-4.6 35.6 1.1 0.9-1.2
Stomach 461.2 8.7 8.3-9.0 259.0 11.0 10.4-11.6 202.2 6.9 6.5-7.3 214.0 3.9 3.7-4.2 125.8 5.4 5.0-5.8 88.2 2.9 2.6-3.1
Colorectal 1943.0 36.5 35.7-37.2 1015.2 42.9 41.7-44.1 927.8 31.4 30.5-32.3 658.4 11.7 11.3-12.1 331.2 14.1 13.4-14.8 327.2 9.9 9.4-10.4
Colon excluding rectum 1375.8 25.6 25.0-26.2 700.6 29.7 28.7-30.7 675.2 22.4 21.7-23.2 535.2 9.5 9.1-9.8 265.0 11.2 10.6-11.9 270.2 8.1 7.7-8.6
Rectum & rectosigmoid 567.2 10.9 10.5-11.3 314.6 13.2 12.6-13.9 252.6 9.0 8.5-9.5 123.2 2.3 2.1-2.5 66.2 2.8 2.5-3.2 57.0 1.8 1.6-2.0
Liver / intrahepatic bile duct 532.2 9.6 9.3-10.0 371.0 15.0 14.3-15.7 161.2 5.2 4.8-5.6 343.6 6.2 5.9-6.5 221.8 9.1 8.6-9.7 121.8 3.8 3.5-4.1
Pancreas 761.6 13.7 13.3-14.2 376.4 15.7 15.0-16.5 385.2 12.1 11.5-12.6 583.8 10.3 10.0-10.7 287.6 12.1 11.5-12.7 296.2 9.0 8.5-9.5
Larynx 151.2 2.8 2.6-3.0 120.0 5.0 4.6-5.4 31.2 1.1 0.9-1.3 48.4 0.9 0.8-1.0 40.6 1.7 1.5-2.0 7.8 0.2 0.2-0.3
Lung and bronchus 2586.6 46.9 46.1-47.7 1252.0 52.6 51.2-53.9 1334.6 43.0 41.9-44.0 1380.4 24.5 24.0-25.1 706.2 29.8 28.8-30.8 674.2 20.7 20.0-21.4
Melanoma of the skin 859.2 16.2 15.8-16.7 485.0 20.6 19.8-21.5 374.2 13.2 12.6-13.8 73.6 1.3 1.2-1.5 44.8 1.9 1.7-2.2 28.8 0.9 0.8-1.1
Female breast             3603.8 132.4 130.4-134.4             555.0 18.0 17.3-18.7
Cervix uteri             187.8 7.5 7.0-8.0             52.8 2.0 1.7-2.2
Corpus uterus and NOS             870.6 30.5 29.6-31.5             174.6 5.6 5.2-6.0
Ovary             323.6 11.6 11.0-12.2             204.0 6.6 6.2-7.1
Prostate       2657.2 106.9 105.1-108.8             355.2 15.3 14.6-16.0      
Testis       164.6 6.8 6.4-7.3             4.2 0.2 0.1-0.3      
Urinary bladder (incl. in situ) 1146.4 20.7 20.1-21.2 859.2 36.4 35.3-37.6 287.2 9.1 8.7-9.6 218.6 3.7 3.5-3.9 151.6 6.5 6.0-7.0 67.0 1.9 1.7-2.1
Kidney and renal pelvis 817.2 15.6 15.1-16.1 531.4 22.2 21.4-23.1 285.8 10.1 9.6-10.7 142.8 2.6 2.4-2.8 93.8 4.0 3.6-4.3 49.0 1.5 1.3-1.7
Brain and other central nervous system 345.0 7.0 6.6-7.3 189.4 8.2 7.7-8.8 155.6 5.9 5.5-6.4 195.8 3.7 3.5-4.0 105.4 4.5 4.1-4.9 90.4 3.1 2.8-3.4
Thyroid 1041.0 21.7 21.1-22.3 266.4 11.3 10.7-12.0 774.6 31.8 30.8-32.9 29.0 0.5 0.4-0.6 10.0 0.4 0.3-0.6 19.0 0.6 0.5-0.7
Hodgkin lymphoma 156.0 3.3 3.1-3.6 86.8 3.8 3.5-4.2 69.2 2.8 2.5-3.1 16.6 0.3 0.2-0.4 10.4 0.4 0.3-0.6 6.2 0.2 0.1-0.3
Non-Hodgkin lymphomas 1192.0 22.6 22.0-23.2 635.6 27.0 26.1-28.0 556.4 19.0 18.3-19.8 269.6 4.8 4.6-5.1 150.8 6.5 6.0-7.0 118.8 3.6 3.3-3.9
Myeloma 405.2 7.4 7.1-7.7 222.2 9.3 8.7-9.8 183.0 6.0 5.6-6.4 135.8 2.4 2.2-2.6 74.0 3.1 2.8-3.5 61.8 1.9 1.7-2.1
Leukemias 829.0 15.9 15.4-16.4 476.8 20.5 19.7-21.4 352.2 12.2 11.6-12.8 307.6 5.6 5.3-5.9 161.6 7.0 6.5-7.5 146.0 4.6 4.3-5.0

Notes

  • Incidence data are provisional, November 2021.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
  • NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.